This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Dr. Aaron Pilling, PhD
Director, Business Development at Wheeler Bio
Speaker

Profile

Aaron Pilling, PhD., enjoys the responsibilities of moving biotechnology products through stages of CMC process design, clinical supply, and commercialization. For nearly 20 years, Aaron has provided expert CMC leadership over a wide range of biologics molecule types, and through multiple stages of development and commercialization. Always underpinning CMC development with sound scientific approaches, rigorous data and statistical analysis and careful documentation strategies, Aaron thrives on leading CMC projects and defining clear visions for programs and molecules, while also empowering and mentoring team members to achieve their—and the project’s— full potential. Aaron is a Director of Business Development at Wheeler Bio and an independent CMC biologics consultant.

Agenda Sessions

  • Advancing Discovery: Leveraging Hybrid-mechanistic Modeling for Development of a Robust mAb Platform Process

    12:00pm